{"id":7775,"date":"2024-05-02T14:41:19","date_gmt":"2024-05-02T12:41:19","guid":{"rendered":"https:\/\/www.forexsrovnavac.cz\/mag\/?p=7775"},"modified":"2025-01-11T17:49:10","modified_gmt":"2025-01-11T16:49:10","slug":"investice-do-leku-na-hubnuti-srovnani-novo-nordisk-a-eli-lilly-co","status":"publish","type":"post","link":"https:\/\/www.forexsrovnavac.cz\/mag\/investice-do-leku-na-hubnuti-srovnani-novo-nordisk-a-eli-lilly-co\/","title":{"rendered":"Investice do l\u00e9k\u016f na hubnut\u00ed: Srovn\u00e1n\u00ed Novo Nordisk a Eli Lilly &#038; Co"},"content":{"rendered":"<ul>\n<li><strong>Novo Nordisk hl\u00e1s\u00ed siln\u00e9 v\u00fdsledky za prvn\u00ed \u010dtvrtlet\u00ed, poh\u00e1n\u011bn\u00e9 Ozempicem a Wegovy<\/strong><\/li>\n<li><strong>Obezita je glob\u00e1ln\u00edm zdravotn\u00edm probl\u00e9mem, co\u017e vede k rostouc\u00ed popt\u00e1vce po l\u00e9\u010db\u011b t\u00e9to choroby. <\/strong><\/li>\n<li><strong>V tomto \u010dl\u00e1nku se pod\u00edv\u00e1me na l\u00e9ky na obezitu jako investi\u010dn\u00ed p\u0159\u00edle\u017eitost a srovn\u00e1me dva hlavn\u00ed hr\u00e1\u010de na trhu: Novo Nordisk a Eli Lilly &amp; Co.<\/strong><\/li>\n<\/ul>\n<p>Farmaceutick\u00e1 spole\u010dnost Novo Nordisk z D\u00e1nska vstoupila do roku 2024 s pozitivn\u00edm impulsem, d\u00edky v\u00fdrazn\u00e9mu n\u00e1r\u016fstu prodeje l\u00e9k\u016f <strong>Ozempic na diabetes a Wegovy na hubnut\u00ed.<\/strong> B\u011bhem prvn\u00edho \u010dtvrtlet\u00ed zaznamenala firma n\u00e1r\u016fst prodeje o 22 %, dosahuj\u00edc celkov\u00fdch tr\u017eeb 65 miliard DKK (9,3 miliardy USD), \u010d\u00edm\u017e op\u011bt p\u0159ed\u010dila o\u010dek\u00e1v\u00e1n\u00ed analytik\u016f.<\/p>\n<div id=\"attachment_9114\" style=\"width: 742px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly.png\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-9114\" class=\"wp-image-9114 size-full\" title=\"Srovn\u00e1n\u00ed Novo Nordisk a Eli Lilly v oblasti l\u00e9k\u016f na hubnut\u00ed\" src=\"https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly.png\" alt=\"\" width=\"742\" height=\"721\" srcset=\"https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly.png 742w, https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly-150x146.png 150w, https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly-41x40.png 41w, https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly-50x50.png 50w, https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly-33x32.png 33w, https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly-82x80.png 82w, https:\/\/www.forexsrovnavac.cz\/mag\/wp-content\/uploads\/2024\/05\/leky-na-hubnuti-novo-nordisk-vs-eli-lilly-139x135.png 139w\" sizes=\"auto, (max-width: 742px) 100vw, 742px\" \/><\/a><p id=\"caption-attachment-9114\" class=\"wp-caption-text\">Srovn\u00e1n\u00ed Novo Nordisk a Eli Lilly v oblasti l\u00e9k\u016f na hubnut\u00ed<\/p><\/div>\n<p>D\u00edky robustn\u00ed hrub\u00e9 mar\u017ei 85 % a provozn\u00ed mar\u017ei 49 % <a href=\"https:\/\/www.forexsrovnavac.cz\/cs\/danske-akcie-kurzy\/novo-nordisk\">Novo Nordisk<\/a> p\u0159etavil sv\u00e9 tr\u017eby na \u010dist\u00fd zisk ve v\u00fd\u0161i 25 miliard DKK (3,6 miliardy USD) a zisk na akcii ve v\u00fd\u0161i 5,70 DKK (0,8 USD), co\u017e p\u0159edstavuje p\u0159ekon\u00e1n\u00ed dokonce i nejvy\u0161\u0161\u00edch o\u010dek\u00e1v\u00e1n\u00ed analytik\u016f.<\/p>\n<p><strong><em>Rostouc\u00ed tr\u017eby spole\u010dnosti Novo Nordisk\u00a0<\/em><\/strong><\/p>\n<stock-market-widget type=\"chart-financials\" template=\"bar\" assets=\"NVO\" report=\"income_statement\" interval=\"quarterly\" fields=\"total_revenue\" border_width=\"2\" display_axes=\"true\" display_legend=\"true\" colors=\"#6fb2e7\" api=\"yahoo-finance\"><\/stock-market-widget>\n<p>Nicm\u00e9n\u011b, je zde je\u0161t\u011b prostor pro dal\u0161\u00ed r\u016fst. Vedle konkurenta <a href=\"https:\/\/www.forexsrovnavac.cz\/cs\/americke-akcie-kurzy\/eli-lilly\">Eli Lilly &amp; Co<\/a> se Novo Nordisk teprve za\u010d\u00edn\u00e1 prosazovat na trhu s l\u00e9\u010dbou obezity, kter\u00fd m\u00e1 potenci\u00e1l pro v\u00edce hr\u00e1\u010d\u016f. I kdy\u017e dosavadn\u00ed kombinovan\u00e9 ro\u010dn\u00ed tr\u017eby obou spole\u010dnost\u00ed za l\u00e9\u010dbu obezity \u010din\u00ed p\u0159ibli\u017en\u011b 7,5 miliardy USD, tato \u010d\u00edsla jsou st\u00e1le daleko pod odhadovanou hodnotou trhu p\u0159es 100 miliard USD do roku 2030.<\/p>\n<p>Eli Lilly &amp; Co, americk\u00e1 farmaceutick\u00e1 spole\u010dnost, tak\u00e9 nab\u00edz\u00ed l\u00e9ky na obezitu, jako je <strong>Trulicity<\/strong>. A\u010dkoliv nem\u00e1 takovou dominanci jako Novo Nordisk, m\u00e1 st\u00e1le siln\u00fd z\u00e1klad z\u00e1kazn\u00edk\u016f a potenci\u00e1l r\u016fstu.<\/p>\n<p><strong><em>Rostouc\u00ed tr\u017eby spole\u010dnosti <\/em>Eli Lilly<\/strong><\/p>\n<stock-market-widget type=\"chart-financials\" template=\"bar\" assets=\"LLY\" report=\"income_statement\" interval=\"quarterly\" border_width=\"2\" display_axes=\"true\" display_legend=\"true\" fields=\"total_revenue\" colors=\"#6fb2e7\" api=\"yahoo-finance\"><\/stock-market-widget>\n<h2>Budouc\u00ed v\u00fdvoj lze t\u011b\u017eko odhadovat<\/h2>\n<p>D\u00edky siln\u00fdm prodej\u016fm v prvn\u00edm \u010dtvrtlet\u00ed byl Novo Nordisk schopen je\u0161t\u011b zv\u00fd\u0161it sv\u00e9 c\u00edle pro rok 2024 o 1 procentn\u00ed bod, p\u0159edpov\u00eddaj\u00edc r\u016fst tr\u017eeb ve v\u00fd\u0161i 19-27 % a r\u016fst provozn\u00edho zisku o 22-30 %.<\/p>\n<p>Nicm\u00e9n\u011b, siln\u00e9 v\u00fdkony spole\u010dnosti Novo Nordisk nemus\u00ed nutn\u011b znamenat stabiln\u00ed v\u00fdvoj na trhu akci\u00ed. Zejm\u00e9na <strong>poskytnut\u00e9 c\u00edle<\/strong> by mohly zklamat n\u011bkter\u00e9 investory, kte\u0159\u00ed se ji\u017e nau\u010dili o\u010dek\u00e1vat optimisti\u010dt\u011bj\u0161\u00ed p\u0159edpov\u011bdi. P\u0159esto\u017ee spole\u010dnost v roce 2023 t\u0159ikr\u00e1t zv\u00fd\u0161ila sv\u00e9 c\u00edle a nakonec dos\u00e1hla skute\u010dn\u00e9ho r\u016fstu tr\u017eeb, kter\u00fd t\u00e9m\u011b\u0159 zdvojn\u00e1sobil p\u016fvodn\u00ed odhady, m\u016f\u017eeme dnes vid\u011bt ur\u010dit\u00fd tlak na pokles v\u00fdkonu akci\u00ed.<\/p>\n<p>A\u010dkoliv Novo Nordisk st\u00e1le ukazuje svou \u00fasp\u011b\u0161nou implementaci, <strong>v\u011bt\u0161ina pozitivn\u00edho v\u00fdvoje ji\u017e byla zohledn\u011bna v cen\u011b akci\u00ed.<\/strong> P\u0159ed zve\u0159ejn\u011bn\u00edm v\u00fdsledk\u016f ji\u017e letos cena akci\u00ed vzrostla o 28 %, n\u00e1sleduj\u00edc\u00ed bullish trend v roce 2023. Hodnota spole\u010dnosti, vyj\u00e1d\u0159en\u00e1 pom\u011brem cena\/zisk kolem 38x, ukazuje, \u017ee investo\u0159i maj\u00ed vysok\u00e1 o\u010dek\u00e1v\u00e1n\u00ed a ji\u017e zahrnuj\u00ed siln\u00fd r\u016fst spole\u010dnosti v p\u0159\u00ed\u0161t\u00edch letech.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk hl\u00e1s\u00ed siln\u00e9 v\u00fdsledky za prvn\u00ed \u010dtvrtlet\u00ed, poh\u00e1n\u011bn\u00e9 Ozempicem a Wegovy Obezita je glob\u00e1ln\u00edm zdravotn\u00edm probl\u00e9mem, co\u017e vede k rostouc\u00ed popt\u00e1vce po l\u00e9\u010db\u011b t\u00e9to choroby. V tomto \u010dl\u00e1nku se pod\u00edv\u00e1me na l\u00e9ky na obezitu jako investi\u010dn\u00ed p\u0159\u00edle\u017eitost a srovn\u00e1me dva hlavn\u00ed hr\u00e1\u010de na trhu: Novo Nordisk a Eli Lilly &amp; Co. Farmaceutick\u00e1 spole\u010dnost Novo [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7778,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"Porovn\u00e1n\u00ed investi\u010dn\u00edch p\u0159\u00edle\u017eitost\u00ed v oblasti l\u00e9\u010dby obezity: anal\u00fdza farmaceutick\u00fdch gigant\u016f Novo Nordisk a Eli Lilly &amp; Co. Kter\u00fd z nich nab\u00edz\u00ed lep\u0161\u00ed potenci\u00e1l pro r\u016fst?","_seopress_robots_index":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[194],"tags":[],"class_list":["post-7775","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-akcie"],"modified_by":"Krpensk\u00fd Martin","_links":{"self":[{"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/posts\/7775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/comments?post=7775"}],"version-history":[{"count":0,"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/posts\/7775\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/media\/7778"}],"wp:attachment":[{"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/media?parent=7775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/categories?post=7775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.forexsrovnavac.cz\/mag\/wp-json\/wp\/v2\/tags?post=7775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}